Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome

Kanai K, Kuwabara S, Misawa S, Hattori T

Neurology · 2012

Grade Bcohortn=23
DOI ↗PubMed ↗

Key Findings

  • ●IL-12 and VEGF markedly elevated in all POEMS patients
  • ●IL-12 and VEGF decrease with treatment, correlating with clinical improvement
  • ●IL-12 proposed as novel biomarker of disease activity

Referenced in (1 disease)

POEMS Syndrome
ID: pmid-22843279DOI: 10.1212/WNL.0b013e318263c42bPMID: 22843279